EXTEND-IA TNK

Project Details

A clinical trial comparing two different clot-dissolving medications in ischemic stroke patients planned for endovascular stroke treatment. EXTEND-IA TNK randomizes patients to alteplase 0.9mg/kg versus tenecteplase 0.25mg/kg The primary outcome is the rate of reperfusion prior to endovascular treatment.

https://www.clinicaltrials.gov/ct2/show/NCT02388061

Funding

  • NHMRC
  • Heart Foundation

Research Group

Stroke Imaging and Treatment


Research Themes

Neuroscience

Areas of Excellence

Neuroscience and Psychiatry


Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Medicine and Radiology